Disc Medicine, Inc. Common Stock (IRON)

FDA rejects Disc Medicine's rare disease drug bitopertin despite a commissioner's voucher, leading to a significant price drop and concerns about a shrinking social community.

About Disc Medicine, Inc. Common Stock

Disc Medicine, Inc. Common Stock (IRON) is a publicly traded stock in the healthcare sector focused on drug development.
Disc Medicine, Inc. Common Stock uses the ticker $IRON for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Disc Medicine, Inc. Common Stock (IRON) trading volume is up 112.7% from the previous week.
Disc Medicine, Inc. Common Stock (IRON) social dominance is up 1808.11% from the previous week.
Disc Medicine, Inc. Common Stock (IRON) creators is up 36.18% from the previous week.
Disc Medicine, Inc. Common Stock (IRON) engagements is up 403.92% from the previous week.
Disc Medicine, Inc. Common Stock (IRON) mentions is up 24.66% from the previous month.
Disc Medicine, Inc. Common Stock (IRON) posts created is up 472.73% from the previous week.
Disc Medicine, Inc. Common Stock entered the top [--] AltRank™ for the first time in [--] days
Disc Medicine, Inc. Common Stock Engagements hit a 52-Week high of [-------] for the day

Price: $56

Price 24-Hour Time-Series Raw Data
The price of IRON has seen a significant drop following the FDA's Complete Response Letter for bitopertin, despite previous recognition as a top gainer. This rejection, coupled with a shrinking social community, is likely driving the negative price action.

24-Hour: -21.89% 7-Day: -23.92% 30-Day: -21.12%

1-Year High: $94.10 on 2025-11-24
1-Year Low: $34.30 on 2025-04-08

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Disc Medicine, Inc. Common Stock (IRON) is currently AltRank #407 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] [----]
[--] Months: [---] [----]
[--] Year: [---] [----]
1-Year High: [-----] on 2026-02-02
1-Year Low: [--] on 2025-10-18

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +6
1-Year High: [--] on 2025-10-20
1-Year Low: [--] on 2025-11-27

Engagements: [------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [-----]
[--] Week: [-------] +404%
[--] Month: [-------] +218%
[--] Months: [---------] +82%
[--] Year: [---------] -53%
1-Year High: [-------] on 2026-02-13
1-Year Low: [---] on 2025-09-14

Engagements by network (24h): TikTok: [--] Reddit: [--] News: [--] X: [------] YouTube: [-----]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +15%
[--] Month: [---] +25%
[--] Months: [-----] +86%
[--] Year: [-----] +19%
1-Year High: [---] on 2025-10-21
1-Year Low: [--] on 2025-09-14

Mentions by network (24h): TikTok: [--] Reddit: [--] News: [--] X: [---] YouTube: [--]

Creators: [---] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Disc Medicine, Inc. Common Stock (IRON) in the last [--] hours which is down 9.80% from [---] in the previous [--] hours Daily Average: [--]
[--] Week: [---] +36%
[--] Month: [---] +24%
[--] Months: [-----] +49%
[--] Year: [-----] +98%
1-Year High: [---] on 2025-10-21
1-Year Low: [--] on 2025-09-19

The most influential creators that mention Disc Medicine, Inc. Common Stock in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@PersimmonTI	[--]	[------]	[--]	[-----]
@RNAiAnalyst	[--]	[------]	[--]	[---]
@BPharmCatalyst	[--]	[------]	[--]	[---]
@BiotechAnalysst	[--]	[-----]	[--]	[---]
@MarcJacksonLA	[--]	[-----]	[--]	[---]
@TimCarmichael3	[--]	[-----]	[--]	[--]
@Milan8o38zb	[--]	[--]	[--]	[--]
@ICHI23101988	[--]	[---]	[--]	[--]
@stocktreats	[--]	[-----]	[--]	[--]
@notreload_ai	[--]	[-----]	[--]	[--]

Sentiment: 44%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 44%
Daily Average: 53%
[--] Week: 36% -47%
[--] Month: 44% +4%
[--] Months: 44% -36%
[--] Year: 44% -42%
1-Year High: 100% on 2025-02-28
1-Year Low: 13% on 2025-12-23

Most Supportive Themes:

Wrapped IRON (wIRON) Launch: (30%) The launch of wIRON on the Base chain is generating positive attention.
Top Gainer Recognition: (15%) Mentions of $IRON as a top gainer on platforms like Coinstore are drawing positive attention.

Most Critical Themes:

Shrinking Social Community: (50%) The social community surrounding IRON is showing signs of shrinkage, which could negatively impact its value.
Negative Sentiment Impact: (5%) Negative sentiment is currently affecting the community's outlook on IRON.

Social Dominance: 0.016%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.016%
Daily Average: 0.013%
[--] Week: 0.071% +0.067%
[--] Month: 0.023% +0.011%
[--] Months: 0.023% +0.015%
[--] Year: 0.023% +0.015%
1-Year High: 0.044% on 2025-10-21
1-Year Low: 0.0015% on 2025-09-19

Market Dominance: 0.0025%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0025%
Daily Average: 0%
1-Year High: 0.139% on 2026-02-06
1-Year Low: 0.0025% on 2026-02-16

Market Cap: $2,204,609,461

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $2,204,609,461
Daily Average: $3,092,424,699
[--] Week: $2,204,986,962 -23%
[--] Month: $2,112,121,564 -21%
1-Year High: $3,552,667,746 on 2025-11-24
1-Year Low: $2,112,121,564 on 2026-02-13

Top Disc Medicine, Inc. Common Stock Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"$IRON FDA Rejects Discs Rare Blood Disease Drug Amid Reports of Prasads Skepticism https://www.biospace.com/fda/fda-rejects-discs-rare-blood-disease-drug-amid-reports-of-prasads-skepticism https://www.biospace.com/fda/fda-rejects-discs-rare-blood-disease-drug-amid-reports-of-prasads-skepticism"
X Link @MarcJacksonLA 2026-02-16T17:08Z [----] followers, [---] engagements

"@augurbio @jlucer53 @Premski_SGP The difference is that $rgnx didnt use a correct surrogate marker and $iron did not even lower ppix to sufficiently low levels for the drug to do anything. Plus th eonly thing that they did to verify is ask patients if they feel better lol. $SPRB has better data. CGMV and cogni"
X Link @Relic57647069 2026-02-16T14:43Z [--] followers, [---] engagements

"$XBI it would really be an incredible shame if Prasad's rejection of $IRON after Makary's providing same with his "Commissioner's Voucher" for priority review was the source of division and rancor between the two leading Makary to question his own decision to aggressively advocate for Prasad's return. would just be incredibly sad to see such a division between two totally effective leaders. The FDA has rejected a rare disease therapy from Disc Medicine an early recipient of a commissioner's voucher from the agency. https://t.co/zxEcFgIqO4 The FDA has rejected a rare disease therapy from Disc"
X Link @PersimmonTI 2026-02-15T19:05Z 10.9K followers, [----] engagements

"how bulletproof is $SPRB's data does the drug work more or less bulletproof than $RGNX $IRON $QURE Not only did $rgnx use a different surrogate biomarket than $sprb to "prove" the efficacy of their drug RGX-121 the cognitive function graphs have uneven axes to mask the declines in the population (on the right). https://t.co/myuTsj0q7d Not only did $rgnx use a different surrogate biomarket than $sprb to "prove" the efficacy of their drug RGX-121 the cognitive function graphs have uneven axes to mask the declines in the population (on the right). https://t.co/myuTsj0q7d"
X Link @abracabrasian 2026-02-15T04:16Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing